In an insured population with advanced lung cancer, clinical trial participants had lower or similar total health care costs compared with nonparticipants.
|Articles|May 1, 2000
Supplements and Featured Publications
- Emerging Drug-Resistant Pathogens in Respiratory Tract Infections: Treatment Options
- Volume 6
- Issue 8 Suppl
Participating Faculty
Advertisement
Articles in this issue
over 26 years ago
Introductionover 26 years ago
Emerging Resistance Problems Among Respiratory Tract Pathogensover 26 years ago
The Importance of Appropriate Treatment of Chronic Bronchitisover 26 years ago
Selected Abstractsover 26 years ago
BibliographyAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
NYC Marathon Death Puts Rhabdomyolysis Risk Factors in Focus
2
Real-World Evidence, Rare Liver Disease Data Headline Kidney Week 2026
3
Acoramidis Linked to Fewer Hospitalizations Than Tafamidis in ATTR-CM
4
Disease Extent Linked to Complications After Deep Endometriosis Surgery
5